Twin Capital Management Inc. Sells 3,831 Shares of Xylem Inc. (NYSE:XYL)

Twin Capital Management Inc. lowered its position in Xylem Inc. (NYSE:XYLFree Report) by 31.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 8,209 shares of the industrial products company’s stock after selling 3,831 shares during the quarter. Twin Capital Management Inc.’s holdings in Xylem were worth $939,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Patten Group Inc. raised its stake in shares of Xylem by 0.3% in the fourth quarter. Patten Group Inc. now owns 31,112 shares of the industrial products company’s stock valued at $3,558,000 after acquiring an additional 99 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Xylem by 4.6% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 2,238 shares of the industrial products company’s stock valued at $256,000 after purchasing an additional 99 shares in the last quarter. Evergreen Capital Management LLC increased its holdings in shares of Xylem by 1.9% in the fourth quarter. Evergreen Capital Management LLC now owns 5,319 shares of the industrial products company’s stock valued at $588,000 after purchasing an additional 100 shares in the last quarter. Harbour Investments Inc. increased its holdings in shares of Xylem by 1.1% in the first quarter. Harbour Investments Inc. now owns 9,017 shares of the industrial products company’s stock valued at $944,000 after purchasing an additional 101 shares in the last quarter. Finally, Boston Trust Walden Corp increased its holdings in shares of Xylem by 3.2% in the fourth quarter. Boston Trust Walden Corp now owns 3,418 shares of the industrial products company’s stock valued at $391,000 after purchasing an additional 107 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

XYL opened at $127.16 on Friday. Xylem Inc. has a 52 week low of $87.59 and a 52 week high of $130.86. The firm has a market capitalization of $30.82 billion, a PE ratio of 46.75, a P/E/G ratio of 2.52 and a beta of 1.10. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.30 and a current ratio of 1.76. The company has a fifty day moving average price of $126.94 and a two-hundred day moving average price of $112.11.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.03. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The company had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.05 billion. During the same quarter in the previous year, the business earned $0.92 EPS. The firm’s revenue was up 40.6% on a year-over-year basis. As a group, analysts anticipate that Xylem Inc. will post 4.13 earnings per share for the current year.

Xylem Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were issued a $0.36 dividend. This is a positive change from Xylem’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, February 20th. This represents a $1.44 annualized dividend and a dividend yield of 1.13%. Xylem’s payout ratio is 52.94%.

Insider Activity

In related news, SVP Franz Cerwinka sold 2,408 shares of the business’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the sale, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at approximately $1,431,032.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares in the company, valued at approximately $360,682.15. The disclosure for this sale can be found here. 0.27% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on XYL shares. Robert W. Baird raised their price target on shares of Xylem from $141.00 to $148.00 and gave the company an “outperform” rating in a report on Thursday, March 21st. Royal Bank of Canada raised their price target on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Wednesday, February 7th. Oppenheimer raised their price target on shares of Xylem from $133.00 to $142.00 and gave the company an “outperform” rating in a report on Thursday. Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a report on Thursday, January 4th. Finally, BNP Paribas began coverage on shares of Xylem in a report on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 price target for the company. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Xylem currently has an average rating of “Moderate Buy” and a consensus price target of $138.11.

Read Our Latest Stock Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Read More

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.